Hogeling SM, Lê DM, La Rose N, Kwon MC, Wierenga AT, van den Heuvel FA, van den Boom V, Kuchnio A, Philippar U, Huls G, Schuringa JJ. Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2024Dec.27];. Available from: https://haematologica.org/article/view/11876